Emodin inhibits proliferation and induces ferroptosis in colon cancer (HT-29, RKO, HCT-15 and SW620) cells by inactivating the NF-κB pathway and nuclear receptor coactivator 4 (NCOA4)-mediated ferritinophagy. Here, NFKB1 is linked to malignant colon neoplasm.